| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233902 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
FIGO Stage III carcinoma of the cervix covers considerably heterogeneous subgroups according to tumor extent. Before initiation of treatment, we suggest that physicians determine a tailored treatment policy based on tumor heterogeneity for each Stage III patient.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yong Bae M.D., Ik Jae M.D., Song Yih M.D., Jun Won M.D., Hong In M.D., Sang Wun M.D., Sunghoon M.D., Young Tae M.D., Chang Ok M.D., Gwi Eon M.D.,